Following the discontinuation of the interfering medication (an aldosterone receptor antagonist), biochemical analysis demonstrated normal plasma renin and aldosterone levels, thereby ruling out the hypothesis of mineralocorticoid excess. Here, NR3C2 is linked to Increased circulating aldosterone concentration.